This brand name is authorized in United States
The drug TAUVID contains one active pharmaceutical ingredient (API):
|
1
Flortaucipir ¹⁸F
UNII T1JP1KYU9O - FLORTAUCIPIR F-18
|
|
Flortaucipir ¹⁸F binds to aggregated tau protein. In the brains of patients with Alzheimer’s disease (AD), tau aggregates combine to form NFTs, one of two components required for the neuropathological diagnosis of AD. Flortaucipir ¹⁸F is indicated for use with positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs). |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| TAUVID Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 0002-1210 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
